Ma YT - Search Results

1

The impact of transarterial chemoembolization induced complications on outcomes after liver transplantation: A propensity-matched study.

Boteon APCDS, Boteon YL, Vinuela EF, Derosas C, Mergental H, Isaac JR, Muiesan P, Mehzard H, Ma YT, Shah T, Mirza DF, Perera MTPR. Boteon APCDS, et al. Among authors: ma yt. Clin Transplant. 2018 May;32(5):e13255. doi: 10.1111/ctr.13255. Epub 2018 May 18. Clin Transplant. 2018. PMID: 29637619 Clinical Trial.

2

Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study.

Primrose JN, Fox RP, Palmer DH, Malik HZ, Prasad R, Mirza D, Anthony A, Corrie P, Falk S, Finch-Jones M, Wasan H, Ross P, Wall L, Wadsley J, Evans JTR, Stocken D, Praseedom R, Ma YT, Davidson B, Neoptolemos JP, Iveson T, Raftery J, Zhu S, Cunningham D, Garden OJ, Stubbs C, Valle JW, Bridgewater J; BILCAP study group. Primrose JN, et al. Among authors: ma yt. Lancet Oncol. 2019 May;20(5):663-673. doi: 10.1016/S1470-2045(18)30915-X. Epub 2019 Mar 25. Lancet Oncol. 2019. PMID: 30922733 Free article. Clinical Trial.

3

Treatment Strategies for the Optimal Management of Locally Advanced Pancreatic Adenocarcinoma With Curative Intent: A Systematic Review.

Attard JA, Farrugia A, Pathanki A, Roberts KJ, Dasari B, Isaac J, Ma YT, Chatzizacharias NA. Attard JA, et al. Among authors: ma yt. Pancreas. 2020 Nov/Dec;49(10):1264-1275. doi: 10.1097/MPA.0000000000001694. Pancreas. 2020. PMID: 33122513

4

The potential of PIVKA-II as a treatment response biomarker in hepatocellular carcinoma: a prospective United Kingdom cohort study.

Sagar VM, Herring K, Curbishley S, Hodson J, Fletcher P, Karkhanis S, Mehrzad H, Punia P, Shah T, Shetty S, Ma YT. Sagar VM, et al. Among authors: ma yt. Oncotarget. 2021 Nov 23;12(24):2338-2350. doi: 10.18632/oncotarget.28136. eCollection 2021 Nov 23. Oncotarget. 2021. PMID: 34853657 Free PMC article.

5

Long-Term Outcomes and Exploratory Analyses of the Randomized Phase III BILCAP Study.

Bridgewater J, Fletcher P, Palmer DH, Malik HZ, Prasad R, Mirza D, Anthony A, Corrie P, Falk S, Finch-Jones M, Wasan H, Ross P, Wall L, Wadsley J, Evans TR, Stocken D, Stubbs C, Praseedom R, Ma YT, Davidson B, Neoptolemos J, Iveson T, Cunningham D, Garden OJ, Valle JW, Primrose J; BILCAP study group. Bridgewater J, et al. Among authors: ma yt. J Clin Oncol. 2022 Jun 20;40(18):2048-2057. doi: 10.1200/JCO.21.02568. Epub 2022 Mar 22. J Clin Oncol. 2022. PMID: 35316080 Clinical Trial.

6

Exceptional serological and radiological response to sorafenib in 2 patients with advanced hepatocellular carcinoma and chronic hepatitis C viral infection: case report and review of the literature.

Atkin C, Earwaker P, Pallan A, Shetty S, Punia P, Ma YT. Atkin C, et al. Among authors: ma yt. BMC Gastroenterol. 2017 Feb 14;17(1):30. doi: 10.1186/s12876-017-0585-x. BMC Gastroenterol. 2017. PMID: 28193171 Free PMC article. Review.

7

Sorafenib in combination with transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma (TACE 2): a randomised placebo-controlled, double-blind, phase 3 trial.

Meyer T, Fox R, Ma YT, Ross PJ, James MW, Sturgess R, Stubbs C, Stocken DD, Wall L, Watkinson A, Hacking N, Evans TRJ, Collins P, Hubner RA, Cunningham D, Primrose JN, Johnson PJ, Palmer DH. Meyer T, et al. Among authors: ma yt. Lancet Gastroenterol Hepatol. 2017 Aug;2(8):565-575. doi: 10.1016/S2468-1253(17)30156-5. Epub 2017 Jun 23. Lancet Gastroenterol Hepatol. 2017. PMID: 28648803 Free article. Clinical Trial.

8

Impact of intensified chemotherapy in metastatic pancreatic ductal adenocarcinoma (PDAC) in clinical routine in Europe.

Javed MA, Beyer G, Le N, Vinci A, Wong H, Palmer D, Morgan RD, Lamarca A, Hubner RA, Valle JW, Alam S, Chowdhury S, Ma YT, Archibugi L, Capurso G, Maisonneuve P, Neesse A, Sund M, Schober M, Krug S. Javed MA, et al. Among authors: ma yt. Pancreatology. 2019 Jan;19(1):97-104. doi: 10.1016/j.pan.2018.10.003. Epub 2018 Oct 15. Pancreatology. 2019. PMID: 30529068

9

Association of Gastric Acid Suppression and Sorafenib Efficacy in Advanced Hepatocellular Carcinoma.

Razak RA, Fletcher P, Kunene V, Ma YT. Razak RA, et al. Among authors: ma yt. J Clin Gastroenterol. 2021 Feb 1;55(2):169-173. doi: 10.1097/MCG.0000000000001375. J Clin Gastroenterol. 2021. PMID: 32520885

10

The prognostic and diagnostic significance of the neutrophil-to-lymphocyte ratio in hepatocellular carcinoma: a prospective controlled study.

Johnson PJ, Dhanaraj S, Berhane S, Bonnett L, Ma YT. Johnson PJ, et al. Among authors: ma yt. Br J Cancer. 2021 Aug;125(5):714-716. doi: 10.1038/s41416-021-01445-3. Epub 2021 Jun 14. Br J Cancer. 2021. PMID: 34127809 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

530 results

Search Page

Filters